ASML's Dividend Cheque Arrives as Shanghai Rivalry and Washington Pressure Test the Bull Case
Published on 08/06/2026 at 02:42 | Redaktion boerse-global.de
The payout lands on a day when the share price is doing anything but celebrating. ASML shareholders collect an interim dividend of €1.88 per share today, yet the stock is down 0.89 percent in Amsterdam trading at €1,470.00 — a modest retreat that masks a more turbulent stretch for Europe's most valuable technology company.
The Dutch lithography giant finds itself caught between two narratives. On one side sits a business firing on all cylinders: raised guidance, record order intake, and a capital returns programme that keeps rewarding investors. On the other lurks a freshly announced Chinese competitor and the spectre of tighter US export restrictions — twin clouds that have knocked the shares well off their highs despite Wall Street's loudest voices urging calm.
The Shanghai factor
The source of recent anxiety is Shanghai Aishengna, which announced in late July that it would begin producing immersion DUV lithography systems. The Chinese manufacturer plans five deliveries this year and up to 20 units in 2027, with domestic chipmakers SMIC, Hua Hong and CXMT named as prospective customers. The news triggered an immediate 7 percent drop in ASML's Amsterdam-listed shares, and the aftershocks continue: on a Nasdaq basis, the stock slid as much as 4 percent intraday on Wednesday before settling around 2 percent lower.
Should investors sell immediately? Or is it worth buying ASML Holding?
Bank of America has pushed back forcefully against the sell-off, calling the reaction an "overreaction." The bank's €2,845 price target on a Nasdaq basis implies upside of more than 70 percent from current levels. Its reasoning is arithmetic: China accounts for roughly 20 percent of ASML's revenue and 44 percent of DUV sales this year, but even if all 20 locally produced immersion tools were deployed, BofA estimates the 2027 revenue impact at just €1.4 billion — a mere 2.4 percent of group sales. Of the 44 analysts covering the stock, 40 rate it a buy.
The broader analyst community leans similarly bullish. JPMorgan lifted its target to $2,400 in mid-July, DZ Bank upgraded to "Strong Buy" around the same time, and Citigroup maintains a "Buy" rating. The consensus sits at "Moderate Buy" with an average price target of $1,970.33 on a Nasdaq basis, though Zacks trimmed its stance to "Hold" in July.
Washington adds to the noise
The competitive threat from Shanghai is compounded by diplomatic friction. The US Commerce Secretary has alleged that an ASML EUV machine could be located in China — equipment whose export to the country is prohibited. ASML CEO Fouquet rejected the claim, pointing to the company's existing export controls. Yet the episode keeps alive the possibility that Washington could further restrict DUV shipments to China, a meaningful risk given that DUV systems — unlike their high-end EUV counterparts — can still be sold there in significant volumes.
The fundamentals underneath
None of this noise has dented the operational story. In mid-July, ASML raised its full-year 2026 outlook, guiding to net sales between €43 billion and €45 billion with a gross margin of 54 to 56 percent. Second-quarter results showed net sales of €9.3 billion and net profit of €2.9 billion. The company also bought back roughly €1.1 billion of its own shares during the quarter, part of a €12.0 billion repurchase programme running from 2026 through 2028 — a steady stream of capital returning to shareholders alongside today's dividend.
Bernstein added its voice to the optimists on Monday, naming ASML one of its "Top Investment Ideas" for the third quarter of 2026 with an "Outperform" rating and a €2,500 price target — comfortably above where the stock trades today. The same day brought news that Glenmede Trust Co. NA trimmed its stake, though such adjustments by individual fund managers are routine for a company with a market capitalisation of €550.88 billion and say little about the underlying business.
ASML Holding at a turning point? This analysis reveals what investors need to know now.
Institutional conviction holds
Large investors remain notably unshaken. By the end of the first quarter of 2026, 133 hedge funds held positions in ASML, up from 101 a year earlier. Emerald Wealth Partners told clients in its second-quarter letter that ASML had risen 51.0 percent in its portfolio, contributing 156 basis points to performance, and described the company's monopoly in advanced lithography as "durable." Goldman Sachs keeps the stock on its conviction list, citing 52 percent upside.
The shares currently sit 15.90 percent below their 52-week high of €1,748.00, having lost 4.80 percent over the past month. But the longer view tells a different story: the stock is up 59.52 percent year to date, and the 52-week low of €588.00 dates back to 6 August 2025 — a reminder of how far the shares have travelled in just over a year. Market chatter about a possible stock split later this year remains unconfirmed by the company.
With ASML due to appear at the Jefferies Semiconductor IT Hardware & Communications Technology Conference in Chicago at the end of August, management will have a platform to address the questions investors are asking. The central one is whether Shanghai Aishengna's immersion DUV output materialises in meaningful volumes — or whether, as Bank of America contends, the market's anxiety has run well ahead of the numbers.
Ad
ASML Holding Stock: New Analysis - 6 August
Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
